Editor’s Note March 6, 2012
Spring is on it’s way and things are heating up as well in the healthcare and life science industry. In […]
Read more »Producer of Advamed 2012, Ray Briscuso Leads One of The Largest MedTech Conferences in a New Direction
AdvaMed 2012, the big medtech conference for industry executives, has launched its website and is calling for proposals for program panels.
Read more »This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Read more »“Inside the FDA” session at BIO CEO Addressed PDUFA and TREAT Acts
This is one of the largest sources of frustration currently among health care companies and investors.
Read more »This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Read more »BIO CEO & Investor Conference Has Grown in Size and Offered Insight on Industry Mood
According to BIO’s statistics, “a majority of investors (56%) still think now is a good time to invest.
Read more »Intellect Neurosciences Files New Patent Applications for Immunotherapy Methods in Treatment of Alzheimer’s Disease
Over the next 40 years, caring for individuals with Alzheimer’s will cost American society $20 trillion –including $15 trillion to Medicare and Medicaid.
Read more »Spherix Closes Registered Direct Offering Of $1.15 Million In Common Stock And Warrants
Spherix has entered into definitive agreements to sell $1.15 million of shares of its common stock and warrants.
Read more »Will Contrast-Induced Nephropathy Kill You?
Contrast-induced nephropathy (CIN) is a form of acute renal failure precipitated by exposure to these radiocontrast agents. In other words, it is hospital-acquired. The question is: will it kill you?
Read more »